nodes	percent_of_prediction	percent_of_DWPC	metapath
Fingolimod—CYP2E1—Pilocarpine—glaucoma	0.113	0.206	CbGbCtD
Fingolimod—CYP2E1—Methazolamide—glaucoma	0.0766	0.139	CbGbCtD
Fingolimod—CYP2D6—Carteolol—glaucoma	0.0713	0.13	CbGbCtD
Fingolimod—CYP2D6—Betaxolol—glaucoma	0.0482	0.0877	CbGbCtD
Fingolimod—CYP2D6—Methazolamide—glaucoma	0.0365	0.0664	CbGbCtD
Fingolimod—CYP3A4—Pilocarpine—glaucoma	0.0344	0.0625	CbGbCtD
Fingolimod—CYP2D6—Timolol—glaucoma	0.031	0.0565	CbGbCtD
Fingolimod—CYP3A4—Brinzolamide—glaucoma	0.027	0.0491	CbGbCtD
Fingolimod—CYP2D6—Clonidine—glaucoma	0.0264	0.048	CbGbCtD
Fingolimod—CYP3A4—Dorzolamide—glaucoma	0.026	0.0474	CbGbCtD
Fingolimod—CYP3A4—Methazolamide—glaucoma	0.0232	0.0423	CbGbCtD
Fingolimod—CYP3A4—Acetazolamide—glaucoma	0.0186	0.0338	CbGbCtD
Fingolimod—CYP3A4—Clonidine—glaucoma	0.0168	0.0305	CbGbCtD
Fingolimod—Mediastinal disorder—Brimonidine—glaucoma	0.000607	0.00221	CcSEcCtD
Fingolimod—Palpitations—Apraclonidine—glaucoma	0.000604	0.00219	CcSEcCtD
Fingolimod—Eye disorder—Travoprost—glaucoma	0.000599	0.00217	CcSEcCtD
Fingolimod—Cardiac disorder—Travoprost—glaucoma	0.000594	0.00216	CcSEcCtD
Fingolimod—Eye disorder—Brinzolamide—glaucoma	0.000591	0.00215	CcSEcCtD
Fingolimod—Mental disorder—Brimonidine—glaucoma	0.00059	0.00214	CcSEcCtD
Fingolimod—Cardiac disorder—Brinzolamide—glaucoma	0.000587	0.00213	CcSEcCtD
Fingolimod—Palpitations—Bimatoprost—glaucoma	0.000585	0.00213	CcSEcCtD
Fingolimod—Angiopathy—Travoprost—glaucoma	0.000581	0.00211	CcSEcCtD
Fingolimod—Cough—Bimatoprost—glaucoma	0.000578	0.0021	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Apraclonidine—glaucoma	0.000577	0.0021	CcSEcCtD
Fingolimod—Mediastinal disorder—Travoprost—glaucoma	0.000577	0.0021	CcSEcCtD
Fingolimod—Angiopathy—Brinzolamide—glaucoma	0.000574	0.00208	CcSEcCtD
Fingolimod—Hypertension—Bimatoprost—glaucoma	0.000572	0.00208	CcSEcCtD
Fingolimod—Asthenia—Carteolol—glaucoma	0.000571	0.00207	CcSEcCtD
Fingolimod—Mediastinal disorder—Brinzolamide—glaucoma	0.00057	0.00207	CcSEcCtD
Fingolimod—Alopecia—Dorzolamide—glaucoma	0.000568	0.00207	CcSEcCtD
Fingolimod—Eye disorder—Pilocarpine—glaucoma	0.000568	0.00206	CcSEcCtD
Fingolimod—Dizziness—Metipranolol—glaucoma	0.000568	0.00206	CcSEcCtD
Fingolimod—Asthenia—Diclofenamide—glaucoma	0.000561	0.00204	CcSEcCtD
Fingolimod—Mental disorder—Travoprost—glaucoma	0.000561	0.00204	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Bimatoprost—glaucoma	0.00056	0.00203	CcSEcCtD
Fingolimod—Alopecia—Brinzolamide—glaucoma	0.000559	0.00203	CcSEcCtD
Fingolimod—Mental disorder—Brinzolamide—glaucoma	0.000554	0.00201	CcSEcCtD
Fingolimod—Infection—Apraclonidine—glaucoma	0.000554	0.00201	CcSEcCtD
Fingolimod—Pruritus—Diclofenamide—glaucoma	0.000553	0.00201	CcSEcCtD
Fingolimod—Eye pain—Timolol—glaucoma	0.000553	0.00201	CcSEcCtD
Fingolimod—Vision blurred—Brimonidine—glaucoma	0.000553	0.00201	CcSEcCtD
Fingolimod—Aspartate aminotransferase increased—Betaxolol—glaucoma	0.00055	0.002	CcSEcCtD
Fingolimod—Leukopenia—Acetazolamide—glaucoma	0.000547	0.00199	CcSEcCtD
Fingolimod—Nervous system disorder—Apraclonidine—glaucoma	0.000547	0.00199	CcSEcCtD
Fingolimod—Back pain—Dorzolamide—glaucoma	0.000542	0.00197	CcSEcCtD
Fingolimod—Skin disorder—Apraclonidine—glaucoma	0.000541	0.00197	CcSEcCtD
Fingolimod—Asthenia—Levobunolol—glaucoma	0.000539	0.00196	CcSEcCtD
Fingolimod—Back pain—Travoprost—glaucoma	0.000539	0.00196	CcSEcCtD
Fingolimod—Depression—Clonidine—glaucoma	0.000539	0.00196	CcSEcCtD
Fingolimod—Alanine aminotransferase increased—Betaxolol—glaucoma	0.000539	0.00196	CcSEcCtD
Fingolimod—Headache—Metipranolol—glaucoma	0.000538	0.00195	CcSEcCtD
Fingolimod—Alopecia—Pilocarpine—glaucoma	0.000537	0.00195	CcSEcCtD
Fingolimod—Infection—Bimatoprost—glaucoma	0.000537	0.00195	CcSEcCtD
Fingolimod—Back pain—Brinzolamide—glaucoma	0.000533	0.00193	CcSEcCtD
Fingolimod—Pruritus—Levobunolol—glaucoma	0.000532	0.00193	CcSEcCtD
Fingolimod—Nervous system disorder—Bimatoprost—glaucoma	0.00053	0.00193	CcSEcCtD
Fingolimod—Influenza—Betaxolol—glaucoma	0.000528	0.00192	CcSEcCtD
Fingolimod—Vision blurred—Dorzolamide—glaucoma	0.000528	0.00192	CcSEcCtD
Fingolimod—Dizziness—Carteolol—glaucoma	0.000526	0.00191	CcSEcCtD
Fingolimod—Vision blurred—Travoprost—glaucoma	0.000525	0.00191	CcSEcCtD
Fingolimod—Skin disorder—Bimatoprost—glaucoma	0.000525	0.00191	CcSEcCtD
Fingolimod—Diarrhoea—Carbachol—glaucoma	0.000522	0.0019	CcSEcCtD
Fingolimod—Vision blurred—Brinzolamide—glaucoma	0.000519	0.00188	CcSEcCtD
Fingolimod—Palpitations—Brimonidine—glaucoma	0.000518	0.00188	CcSEcCtD
Fingolimod—Dizziness—Diclofenamide—glaucoma	0.000517	0.00188	CcSEcCtD
Fingolimod—Asthenia—Methazolamide—glaucoma	0.000517	0.00188	CcSEcCtD
Fingolimod—Diarrhoea—Levobunolol—glaucoma	0.000514	0.00187	CcSEcCtD
Fingolimod—Back pain—Pilocarpine—glaucoma	0.000512	0.00186	CcSEcCtD
Fingolimod—Cough—Brimonidine—glaucoma	0.000512	0.00186	CcSEcCtD
Fingolimod—Cerebrovascular accident—Timolol—glaucoma	0.000509	0.00185	CcSEcCtD
Fingolimod—Bronchitis—Betaxolol—glaucoma	0.000508	0.00184	CcSEcCtD
Fingolimod—Hypertension—Brimonidine—glaucoma	0.000506	0.00184	CcSEcCtD
Fingolimod—Dizziness—Carbachol—glaucoma	0.000505	0.00183	CcSEcCtD
Fingolimod—Paraesthesia—Apraclonidine—glaucoma	0.000501	0.00182	CcSEcCtD
Fingolimod—Vision blurred—Pilocarpine—glaucoma	0.000499	0.00181	CcSEcCtD
Fingolimod—Headache—Carteolol—glaucoma	0.000498	0.00181	CcSEcCtD
Fingolimod—Dizziness—Levobunolol—glaucoma	0.000497	0.00181	CcSEcCtD
Fingolimod—Dyspnoea—Apraclonidine—glaucoma	0.000497	0.00181	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Brimonidine—glaucoma	0.000496	0.0018	CcSEcCtD
Fingolimod—Palpitations—Dorzolamide—glaucoma	0.000495	0.0018	CcSEcCtD
Fingolimod—Bradycardia—Clonidine—glaucoma	0.000494	0.0018	CcSEcCtD
Fingolimod—Pruritus—Latanoprost—glaucoma	0.000493	0.00179	CcSEcCtD
Fingolimod—Diarrhoea—Methazolamide—glaucoma	0.000493	0.00179	CcSEcCtD
Fingolimod—Palpitations—Travoprost—glaucoma	0.000493	0.00179	CcSEcCtD
Fingolimod—Headache—Diclofenamide—glaucoma	0.00049	0.00178	CcSEcCtD
Fingolimod—Cough—Dorzolamide—glaucoma	0.000489	0.00178	CcSEcCtD
Fingolimod—Cough—Travoprost—glaucoma	0.000487	0.00177	CcSEcCtD
Fingolimod—Palpitations—Brinzolamide—glaucoma	0.000486	0.00177	CcSEcCtD
Fingolimod—Hypertension—Dorzolamide—glaucoma	0.000483	0.00176	CcSEcCtD
Fingolimod—Dyspnoea—Bimatoprost—glaucoma	0.000482	0.00175	CcSEcCtD
Fingolimod—Hypertension—Travoprost—glaucoma	0.000481	0.00175	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Apraclonidine—glaucoma	0.000481	0.00175	CcSEcCtD
Fingolimod—Fatigue—Apraclonidine—glaucoma	0.000481	0.00175	CcSEcCtD
Fingolimod—Cough—Brinzolamide—glaucoma	0.00048	0.00175	CcSEcCtD
Fingolimod—Headache—Carbachol—glaucoma	0.000478	0.00174	CcSEcCtD
Fingolimod—Weight decreased—Betaxolol—glaucoma	0.000478	0.00174	CcSEcCtD
Fingolimod—Infection—Brimonidine—glaucoma	0.000475	0.00173	CcSEcCtD
Fingolimod—Hypertension—Brinzolamide—glaucoma	0.000475	0.00173	CcSEcCtD
Fingolimod—Cardiac arrest—Timolol—glaucoma	0.000475	0.00172	CcSEcCtD
Fingolimod—Leukopenia—Pilocarpine—glaucoma	0.000474	0.00172	CcSEcCtD
Fingolimod—Pneumonia—Betaxolol—glaucoma	0.000473	0.00172	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Travoprost—glaucoma	0.000471	0.00171	CcSEcCtD
Fingolimod—Headache—Levobunolol—glaucoma	0.000471	0.00171	CcSEcCtD
Fingolimod—Infestation—Betaxolol—glaucoma	0.000471	0.00171	CcSEcCtD
Fingolimod—Infestation NOS—Betaxolol—glaucoma	0.000471	0.00171	CcSEcCtD
Fingolimod—Depression—Betaxolol—glaucoma	0.000469	0.00171	CcSEcCtD
Fingolimod—Nervous system disorder—Brimonidine—glaucoma	0.000469	0.0017	CcSEcCtD
Fingolimod—Palpitations—Pilocarpine—glaucoma	0.000468	0.0017	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Bimatoprost—glaucoma	0.000467	0.0017	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Brinzolamide—glaucoma	0.000465	0.00169	CcSEcCtD
Fingolimod—Skin disorder—Brimonidine—glaucoma	0.000465	0.00169	CcSEcCtD
Fingolimod—Cough—Pilocarpine—glaucoma	0.000462	0.00168	CcSEcCtD
Fingolimod—Dizziness—Latanoprost—glaucoma	0.000461	0.00168	CcSEcCtD
Fingolimod—Liver function test abnormal—Timolol—glaucoma	0.000461	0.00167	CcSEcCtD
Fingolimod—Hypertension—Pilocarpine—glaucoma	0.000457	0.00166	CcSEcCtD
Fingolimod—Eye disorder—Clonidine—glaucoma	0.000454	0.00165	CcSEcCtD
Fingolimod—Infection—Travoprost—glaucoma	0.000452	0.00164	CcSEcCtD
Fingolimod—Headache—Methazolamide—glaucoma	0.000451	0.00164	CcSEcCtD
Fingolimod—Cardiac disorder—Clonidine—glaucoma	0.00045	0.00164	CcSEcCtD
Fingolimod—Paraesthesia—Acetazolamide—glaucoma	0.000448	0.00163	CcSEcCtD
Fingolimod—Hypotension—Brimonidine—glaucoma	0.000447	0.00162	CcSEcCtD
Fingolimod—Infection—Brinzolamide—glaucoma	0.000446	0.00162	CcSEcCtD
Fingolimod—Nervous system disorder—Travoprost—glaucoma	0.000446	0.00162	CcSEcCtD
Fingolimod—Skin disorder—Travoprost—glaucoma	0.000442	0.00161	CcSEcCtD
Fingolimod—Sinusitis—Betaxolol—glaucoma	0.000442	0.0016	CcSEcCtD
Fingolimod—Nervous system disorder—Brinzolamide—glaucoma	0.000441	0.0016	CcSEcCtD
Fingolimod—Angiopathy—Clonidine—glaucoma	0.00044	0.0016	CcSEcCtD
Fingolimod—Mediastinal disorder—Clonidine—glaucoma	0.000437	0.00159	CcSEcCtD
Fingolimod—Headache—Latanoprost—glaucoma	0.000437	0.00159	CcSEcCtD
Fingolimod—Skin disorder—Brinzolamide—glaucoma	0.000436	0.00159	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Acetazolamide—glaucoma	0.00043	0.00156	CcSEcCtD
Fingolimod—Bradycardia—Betaxolol—glaucoma	0.00043	0.00156	CcSEcCtD
Fingolimod—Fatigue—Acetazolamide—glaucoma	0.00043	0.00156	CcSEcCtD
Fingolimod—Paraesthesia—Brimonidine—glaucoma	0.00043	0.00156	CcSEcCtD
Fingolimod—Infection—Pilocarpine—glaucoma	0.000429	0.00156	CcSEcCtD
Fingolimod—Alopecia—Clonidine—glaucoma	0.000429	0.00156	CcSEcCtD
Fingolimod—Hypotension—Dorzolamide—glaucoma	0.000427	0.00155	CcSEcCtD
Fingolimod—Dyspnoea—Brimonidine—glaucoma	0.000427	0.00155	CcSEcCtD
Fingolimod—Mental disorder—Clonidine—glaucoma	0.000425	0.00155	CcSEcCtD
Fingolimod—Hypotension—Travoprost—glaucoma	0.000425	0.00154	CcSEcCtD
Fingolimod—Hypotension—Brinzolamide—glaucoma	0.00042	0.00153	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Brimonidine—glaucoma	0.000413	0.0015	CcSEcCtD
Fingolimod—Fatigue—Brimonidine—glaucoma	0.000413	0.0015	CcSEcCtD
Fingolimod—Paraesthesia—Dorzolamide—glaucoma	0.00041	0.00149	CcSEcCtD
Fingolimod—Dyspnoea—Dorzolamide—glaucoma	0.000407	0.00148	CcSEcCtD
Fingolimod—Dyspnoea—Travoprost—glaucoma	0.000406	0.00147	CcSEcCtD
Fingolimod—Hypotension—Pilocarpine—glaucoma	0.000404	0.00147	CcSEcCtD
Fingolimod—Paraesthesia—Brinzolamide—glaucoma	0.000403	0.00147	CcSEcCtD
Fingolimod—Dyspnoea—Brinzolamide—glaucoma	0.000401	0.00146	CcSEcCtD
Fingolimod—Asthenia—Apraclonidine—glaucoma	0.0004	0.00145	CcSEcCtD
Fingolimod—Vision blurred—Clonidine—glaucoma	0.000398	0.00145	CcSEcCtD
Fingolimod—Eye disorder—Betaxolol—glaucoma	0.000395	0.00143	CcSEcCtD
Fingolimod—Pruritus—Apraclonidine—glaucoma	0.000394	0.00143	CcSEcCtD
Fingolimod—Fatigue—Dorzolamide—glaucoma	0.000394	0.00143	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Travoprost—glaucoma	0.000393	0.00143	CcSEcCtD
Fingolimod—Fatigue—Travoprost—glaucoma	0.000392	0.00143	CcSEcCtD
Fingolimod—Cardiac disorder—Betaxolol—glaucoma	0.000392	0.00142	CcSEcCtD
Fingolimod—Weight decreased—Timolol—glaucoma	0.00039	0.00142	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Brinzolamide—glaucoma	0.000388	0.00141	CcSEcCtD
Fingolimod—Paraesthesia—Pilocarpine—glaucoma	0.000388	0.00141	CcSEcCtD
Fingolimod—Asthenia—Bimatoprost—glaucoma	0.000388	0.00141	CcSEcCtD
Fingolimod—Fatigue—Brinzolamide—glaucoma	0.000387	0.00141	CcSEcCtD
Fingolimod—Dyspnoea—Pilocarpine—glaucoma	0.000385	0.0014	CcSEcCtD
Fingolimod—Depression—Timolol—glaucoma	0.000383	0.00139	CcSEcCtD
Fingolimod—Angiopathy—Betaxolol—glaucoma	0.000383	0.00139	CcSEcCtD
Fingolimod—Pruritus—Bimatoprost—glaucoma	0.000382	0.00139	CcSEcCtD
Fingolimod—Diarrhoea—Apraclonidine—glaucoma	0.000381	0.00139	CcSEcCtD
Fingolimod—Mediastinal disorder—Betaxolol—glaucoma	0.000381	0.00138	CcSEcCtD
Fingolimod—Alopecia—Betaxolol—glaucoma	0.000373	0.00136	CcSEcCtD
Fingolimod—Palpitations—Clonidine—glaucoma	0.000373	0.00136	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Pilocarpine—glaucoma	0.000373	0.00135	CcSEcCtD
Fingolimod—Mental disorder—Betaxolol—glaucoma	0.00037	0.00135	CcSEcCtD
Fingolimod—Cough—Clonidine—glaucoma	0.000369	0.00134	CcSEcCtD
Fingolimod—Dizziness—Apraclonidine—glaucoma	0.000369	0.00134	CcSEcCtD
Fingolimod—Sinusitis—Timolol—glaucoma	0.000361	0.00131	CcSEcCtD
Fingolimod—Asthenia—Acetazolamide—glaucoma	0.000358	0.0013	CcSEcCtD
Fingolimod—Dizziness—Bimatoprost—glaucoma	0.000357	0.0013	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	0.000357	0.0013	CcSEcCtD
Fingolimod—Bradycardia—Timolol—glaucoma	0.000351	0.00128	CcSEcCtD
Fingolimod—Headache—Apraclonidine—glaucoma	0.000349	0.00127	CcSEcCtD
Fingolimod—Vision blurred—Betaxolol—glaucoma	0.000347	0.00126	CcSEcCtD
Fingolimod—Asthenia—Brimonidine—glaucoma	0.000343	0.00125	CcSEcCtD
Fingolimod—Infection—Clonidine—glaucoma	0.000343	0.00124	CcSEcCtD
Fingolimod—Diarrhoea—Acetazolamide—glaucoma	0.000341	0.00124	CcSEcCtD
Fingolimod—Connective tissue disorder—Timolol—glaucoma	0.000339	0.00123	CcSEcCtD
Fingolimod—Pruritus—Brimonidine—glaucoma	0.000339	0.00123	CcSEcCtD
Fingolimod—Headache—Bimatoprost—glaucoma	0.000339	0.00123	CcSEcCtD
Fingolimod—Nervous system disorder—Clonidine—glaucoma	0.000338	0.00123	CcSEcCtD
Fingolimod—Skin disorder—Clonidine—glaucoma	0.000335	0.00122	CcSEcCtD
Fingolimod—Dizziness—Acetazolamide—glaucoma	0.00033	0.0012	CcSEcCtD
Fingolimod—Asthenia—Dorzolamide—glaucoma	0.000328	0.00119	CcSEcCtD
Fingolimod—Asthenia—Travoprost—glaucoma	0.000326	0.00119	CcSEcCtD
Fingolimod—Palpitations—Betaxolol—glaucoma	0.000325	0.00118	CcSEcCtD
Fingolimod—Pruritus—Dorzolamide—glaucoma	0.000323	0.00117	CcSEcCtD
Fingolimod—Eye disorder—Timolol—glaucoma	0.000323	0.00117	CcSEcCtD
Fingolimod—Asthenia—Brinzolamide—glaucoma	0.000322	0.00117	CcSEcCtD
Fingolimod—Hypotension—Clonidine—glaucoma	0.000322	0.00117	CcSEcCtD
Fingolimod—Pruritus—Travoprost—glaucoma	0.000322	0.00117	CcSEcCtD
Fingolimod—Cough—Betaxolol—glaucoma	0.000321	0.00117	CcSEcCtD
Fingolimod—Cardiac disorder—Timolol—glaucoma	0.00032	0.00116	CcSEcCtD
Fingolimod—Pruritus—Brinzolamide—glaucoma	0.000318	0.00115	CcSEcCtD
Fingolimod—Dizziness—Brimonidine—glaucoma	0.000316	0.00115	CcSEcCtD
Fingolimod—Angiopathy—Timolol—glaucoma	0.000313	0.00114	CcSEcCtD
Fingolimod—Diarrhoea—Dorzolamide—glaucoma	0.000313	0.00114	CcSEcCtD
Fingolimod—Headache—Acetazolamide—glaucoma	0.000312	0.00113	CcSEcCtD
Fingolimod—Diarrhoea—Travoprost—glaucoma	0.000311	0.00113	CcSEcCtD
Fingolimod—Mediastinal disorder—Timolol—glaucoma	0.000311	0.00113	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	0.000311	0.00113	CcSEcCtD
Fingolimod—Asthenia—Pilocarpine—glaucoma	0.00031	0.00113	CcSEcCtD
Fingolimod—Paraesthesia—Clonidine—glaucoma	0.00031	0.00113	CcSEcCtD
Fingolimod—Dyspnoea—Clonidine—glaucoma	0.000307	0.00112	CcSEcCtD
Fingolimod—Diarrhoea—Brinzolamide—glaucoma	0.000307	0.00112	CcSEcCtD
Fingolimod—Pruritus—Pilocarpine—glaucoma	0.000306	0.00111	CcSEcCtD
Fingolimod—Alopecia—Timolol—glaucoma	0.000305	0.00111	CcSEcCtD
Fingolimod—Mental disorder—Timolol—glaucoma	0.000302	0.0011	CcSEcCtD
Fingolimod—Dizziness—Dorzolamide—glaucoma	0.000302	0.0011	CcSEcCtD
Fingolimod—Dizziness—Travoprost—glaucoma	0.000301	0.00109	CcSEcCtD
Fingolimod—Headache—Brimonidine—glaucoma	0.0003	0.00109	CcSEcCtD
Fingolimod—Infection—Betaxolol—glaucoma	0.000298	0.00108	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Clonidine—glaucoma	0.000298	0.00108	CcSEcCtD
Fingolimod—Fatigue—Clonidine—glaucoma	0.000297	0.00108	CcSEcCtD
Fingolimod—Dizziness—Brinzolamide—glaucoma	0.000297	0.00108	CcSEcCtD
Fingolimod—Diarrhoea—Pilocarpine—glaucoma	0.000295	0.00107	CcSEcCtD
Fingolimod—Nervous system disorder—Betaxolol—glaucoma	0.000294	0.00107	CcSEcCtD
Fingolimod—Skin disorder—Betaxolol—glaucoma	0.000292	0.00106	CcSEcCtD
Fingolimod—Headache—Dorzolamide—glaucoma	0.000286	0.00104	CcSEcCtD
Fingolimod—Dizziness—Pilocarpine—glaucoma	0.000286	0.00104	CcSEcCtD
Fingolimod—S1PR3—Signaling Pathways—PTGFR—glaucoma	0.000285	0.00163	CbGpPWpGaD
Fingolimod—Headache—Travoprost—glaucoma	0.000285	0.00104	CcSEcCtD
Fingolimod—S1PR1—GPCR ligand binding—EDN1—glaucoma	0.000284	0.00162	CbGpPWpGaD
Fingolimod—S1PR4—GPCR ligand binding—C3—glaucoma	0.000284	0.00162	CbGpPWpGaD
Fingolimod—Vision blurred—Timolol—glaucoma	0.000283	0.00103	CcSEcCtD
Fingolimod—SPHK1—Metabolism—CA1—glaucoma	0.000283	0.00162	CbGpPWpGaD
Fingolimod—Headache—Brinzolamide—glaucoma	0.000281	0.00102	CcSEcCtD
Fingolimod—Hypotension—Betaxolol—glaucoma	0.000281	0.00102	CcSEcCtD
Fingolimod—SPHK1—Metabolism—CTSA—glaucoma	0.000274	0.00156	CbGpPWpGaD
Fingolimod—S1PR5—GPCR ligand binding—C3—glaucoma	0.000273	0.00156	CbGpPWpGaD
Fingolimod—S1PR3—GPCR ligand binding—C3—glaucoma	0.000273	0.00156	CbGpPWpGaD
Fingolimod—Headache—Pilocarpine—glaucoma	0.000271	0.000983	CcSEcCtD
Fingolimod—CYP3A4—Tamoxifen metabolism—CYP1B1—glaucoma	0.00027	0.00154	CbGpPWpGaD
Fingolimod—Paraesthesia—Betaxolol—glaucoma	0.00027	0.000979	CcSEcCtD
Fingolimod—Dyspnoea—Betaxolol—glaucoma	0.000268	0.000972	CcSEcCtD
Fingolimod—S1PR1—Signaling Pathways—HEYL—glaucoma	0.000267	0.00153	CbGpPWpGaD
Fingolimod—Palpitations—Timolol—glaucoma	0.000266	0.000965	CcSEcCtD
Fingolimod—Cough—Timolol—glaucoma	0.000262	0.000953	CcSEcCtD
Fingolimod—SPHK1—Metabolism of proteins—PAX6—glaucoma	0.000261	0.00149	CbGpPWpGaD
Fingolimod—Hypertension—Timolol—glaucoma	0.000259	0.000943	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Betaxolol—glaucoma	0.000259	0.000942	CcSEcCtD
Fingolimod—S1PR1—Signaling Pathways—PTGFR—glaucoma	0.000259	0.00148	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—CA2—glaucoma	0.000259	0.00148	CbGpPWpGaD
Fingolimod—Fatigue—Betaxolol—glaucoma	0.000259	0.00094	CcSEcCtD
Fingolimod—CYP2D6—Melatonin metabolism and effects—EDN1—glaucoma	0.000258	0.00147	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—OPN4—glaucoma	0.000255	0.00145	CbGpPWpGaD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	0.000254	0.000923	CcSEcCtD
Fingolimod—SPHK1—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	0.000253	0.00144	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	0.000253	0.00144	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—SMO—glaucoma	0.000253	0.00144	CbGpPWpGaD
Fingolimod—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000251	0.00143	CbGpPWpGaD
Fingolimod—S1PR1—GPCR ligand binding—C3—glaucoma	0.000248	0.00142	CbGpPWpGaD
Fingolimod—CYP2E1—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000248	0.00142	CbGpPWpGaD
Fingolimod—Asthenia—Clonidine—glaucoma	0.000247	0.000899	CcSEcCtD
Fingolimod—CYP4F12—Metabolism—TXN—glaucoma	0.000246	0.0014	CbGpPWpGaD
Fingolimod—CYP3A4—Estrogen metabolism—GSTM1—glaucoma	0.000244	0.00139	CbGpPWpGaD
Fingolimod—Pruritus—Clonidine—glaucoma	0.000244	0.000886	CcSEcCtD
Fingolimod—Infection—Timolol—glaucoma	0.000244	0.000885	CcSEcCtD
Fingolimod—S1PR5—Signaling by GPCR—SMO—glaucoma	0.000244	0.00139	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—SMO—glaucoma	0.000244	0.00139	CbGpPWpGaD
Fingolimod—Nervous system disorder—Timolol—glaucoma	0.000241	0.000874	CcSEcCtD
Fingolimod—Skin disorder—Timolol—glaucoma	0.000238	0.000866	CcSEcCtD
Fingolimod—SPHK1—Signaling Pathways—HEYL—glaucoma	0.000237	0.00135	CbGpPWpGaD
Fingolimod—Diarrhoea—Clonidine—glaucoma	0.000236	0.000857	CcSEcCtD
Fingolimod—S1PR4—Signaling Pathways—RPTOR—glaucoma	0.000232	0.00132	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—PTGFR—glaucoma	0.000229	0.00131	CbGpPWpGaD
Fingolimod—Hypotension—Timolol—glaucoma	0.000229	0.000833	CcSEcCtD
Fingolimod—Dizziness—Clonidine—glaucoma	0.000228	0.000829	CcSEcCtD
Fingolimod—S1PR4—Signaling Pathways—NCK2—glaucoma	0.000225	0.00128	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—RPTOR—glaucoma	0.000223	0.00127	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—RPTOR—glaucoma	0.000223	0.00127	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—SMO—glaucoma	0.000221	0.00126	CbGpPWpGaD
Fingolimod—Paraesthesia—Timolol—glaucoma	0.00022	0.0008	CcSEcCtD
Fingolimod—Dyspnoea—Timolol—glaucoma	0.000219	0.000794	CcSEcCtD
Fingolimod—S1PR5—Signaling Pathways—NCK2—glaucoma	0.000216	0.00123	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—NCK2—glaucoma	0.000216	0.00123	CbGpPWpGaD
Fingolimod—Headache—Clonidine—glaucoma	0.000216	0.000785	CcSEcCtD
Fingolimod—Asthenia—Betaxolol—glaucoma	0.000215	0.000783	CcSEcCtD
Fingolimod—Pruritus—Betaxolol—glaucoma	0.000212	0.000772	CcSEcCtD
Fingolimod—CYP4F2—Metabolism—TXN—glaucoma	0.000212	0.00121	CbGpPWpGaD
Fingolimod—Gastrointestinal disorder—Timolol—glaucoma	0.000212	0.000769	CcSEcCtD
Fingolimod—Fatigue—Timolol—glaucoma	0.000211	0.000768	CcSEcCtD
Fingolimod—CYP2D6—Melatonin metabolism and effects—APOE—glaucoma	0.00021	0.0012	CbGpPWpGaD
Fingolimod—Diarrhoea—Betaxolol—glaucoma	0.000205	0.000746	CcSEcCtD
Fingolimod—CYP2E1—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000204	0.00116	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—RPTOR—glaucoma	0.000203	0.00116	CbGpPWpGaD
Fingolimod—Dizziness—Betaxolol—glaucoma	0.000199	0.000721	CcSEcCtD
Fingolimod—S1PR1—Signaling Pathways—NCK2—glaucoma	0.000196	0.00112	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism of lipids and lipoproteins—APOE—glaucoma	0.000194	0.00111	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism of lipids and lipoproteins—CAV1—glaucoma	0.000192	0.0011	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—HDAC9—glaucoma	0.000191	0.00109	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—GSTT1—glaucoma	0.000191	0.00109	CbGpPWpGaD
Fingolimod—Headache—Betaxolol—glaucoma	0.000188	0.000683	CcSEcCtD
Fingolimod—S1PR3—Signaling Pathways—HDAC9—glaucoma	0.000184	0.00105	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—HDAC9—glaucoma	0.000184	0.00105	CbGpPWpGaD
Fingolimod—S1PR4—GPCR downstream signaling—EDN1—glaucoma	0.000184	0.00105	CbGpPWpGaD
Fingolimod—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.000184	0.00105	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—TXN—glaucoma	0.000182	0.00104	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—RPTOR—glaucoma	0.000179	0.00102	CbGpPWpGaD
Fingolimod—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000178	0.00102	CbGpPWpGaD
Fingolimod—S1PR5—GPCR downstream signaling—EDN1—glaucoma	0.000177	0.00101	CbGpPWpGaD
Fingolimod—S1PR3—GPCR downstream signaling—EDN1—glaucoma	0.000177	0.00101	CbGpPWpGaD
Fingolimod—Asthenia—Timolol—glaucoma	0.000176	0.000639	CcSEcCtD
Fingolimod—CYP2D6—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000176	0.001	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—NCK2—glaucoma	0.000174	0.000992	CbGpPWpGaD
Fingolimod—Pruritus—Timolol—glaucoma	0.000174	0.00063	CcSEcCtD
Fingolimod—Diarrhoea—Timolol—glaucoma	0.000168	0.00061	CcSEcCtD
Fingolimod—S1PR1—Signaling Pathways—HDAC9—glaucoma	0.000167	0.000953	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—EDN1—glaucoma	0.000167	0.000952	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism of lipids and lipoproteins—APOE—glaucoma	0.000166	0.00095	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism of lipids and lipoproteins—CAV1—glaucoma	0.000165	0.000941	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—GSTT1—glaucoma	0.000165	0.00094	CbGpPWpGaD
Fingolimod—Dizziness—Timolol—glaucoma	0.000162	0.000589	CcSEcCtD
Fingolimod—S1PR5—Signaling by GPCR—EDN1—glaucoma	0.000161	0.000916	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—EDN1—glaucoma	0.000161	0.000916	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—EDN1—glaucoma	0.000161	0.000916	CbGpPWpGaD
Fingolimod—S1PR4—GPCR downstream signaling—C3—glaucoma	0.00016	0.000916	CbGpPWpGaD
Fingolimod—S1PR5—GPCR downstream signaling—C3—glaucoma	0.000154	0.000881	CbGpPWpGaD
Fingolimod—S1PR3—GPCR downstream signaling—C3—glaucoma	0.000154	0.000881	CbGpPWpGaD
Fingolimod—Headache—Timolol—glaucoma	0.000154	0.000558	CcSEcCtD
Fingolimod—CYP4F12—Metabolism—CYP1B1—glaucoma	0.000152	0.000867	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—ABCA1—glaucoma	0.000152	0.000867	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—SMO—glaucoma	0.000149	0.000853	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism of proteins—MMP1—glaucoma	0.000149	0.000848	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—HDAC9—glaucoma	0.000148	0.000843	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—EDN1—glaucoma	0.000146	0.000832	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—C3—glaucoma	0.000146	0.000832	CbGpPWpGaD
Fingolimod—CYP2D6—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000145	0.000825	CbGpPWpGaD
Fingolimod—CYP3A4—Tryptophan metabolism—CYP1B1—glaucoma	0.000144	0.000823	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—SMO—glaucoma	0.000144	0.000821	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—SMO—glaucoma	0.000144	0.000821	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—GSTT1—glaucoma	0.000141	0.000807	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—C3—glaucoma	0.00014	0.0008	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—C3—glaucoma	0.00014	0.0008	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—C3—glaucoma	0.00014	0.0008	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—NTRK2—glaucoma	0.000137	0.00078	CbGpPWpGaD
Fingolimod—CYP2E1—Biological oxidations—GSTT1—glaucoma	0.000136	0.000775	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	0.000133	0.000758	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—NTRK2—glaucoma	0.000132	0.000751	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—NTRK2—glaucoma	0.000132	0.000751	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—ABCA1—glaucoma	0.000131	0.000749	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—CYP1B1—glaucoma	0.000131	0.000749	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—SMO—glaucoma	0.000131	0.000746	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—C3—glaucoma	0.000127	0.000727	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—GSTM1—glaucoma	0.000121	0.000693	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—NTRK2—glaucoma	0.000119	0.000682	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—NGFR—glaucoma	0.000117	0.000669	CbGpPWpGaD
Fingolimod—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000117	0.000665	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—SMO—glaucoma	0.000116	0.00066	CbGpPWpGaD
Fingolimod—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000115	0.000657	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism of proteins—MMP2—glaucoma	0.000115	0.000656	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	0.000114	0.000651	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—NGFR—glaucoma	0.000113	0.000644	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—NGFR—glaucoma	0.000113	0.000644	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—CYP1B1—glaucoma	0.000113	0.000643	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—ABCA1—glaucoma	0.000113	0.000643	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—NTRK1—glaucoma	0.000111	0.000636	CbGpPWpGaD
Fingolimod—CYP2E1—Biological oxidations—CYP1B1—glaucoma	0.000108	0.000617	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—MTHFR—glaucoma	0.000107	0.000613	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—NTRK1—glaucoma	0.000107	0.000612	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—NTRK1—glaucoma	0.000107	0.000612	CbGpPWpGaD
Fingolimod—CYP2E1—Metapathway biotransformation—CYP1B1—glaucoma	0.000107	0.000609	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—NTRK2—glaucoma	0.000106	0.000603	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—GSTM1—glaucoma	0.000105	0.000599	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—CDKN2B—glaucoma	0.000103	0.000586	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—NGFR—glaucoma	0.000103	0.000585	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—APOE—glaucoma	0.0001	0.00057	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—CAV1—glaucoma	9.9e-05	0.000565	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—CDKN2B—glaucoma	9.88e-05	0.000564	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—CDKN2B—glaucoma	9.88e-05	0.000564	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—EDN1—glaucoma	9.85e-05	0.000562	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—NTRK1—glaucoma	9.74e-05	0.000556	CbGpPWpGaD
Fingolimod—CYP2D6—Biological oxidations—GSTT1—glaucoma	9.64e-05	0.00055	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—CA5A—glaucoma	9.52e-05	0.000543	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—NARFL—glaucoma	9.52e-05	0.000543	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—EDN1—glaucoma	9.48e-05	0.000541	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—EDN1—glaucoma	9.48e-05	0.000541	CbGpPWpGaD
Fingolimod—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	9.45e-05	0.000539	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—MTHFR—glaucoma	9.27e-05	0.000529	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—NGFR—glaucoma	9.07e-05	0.000518	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—NGF—glaucoma	9.05e-05	0.000517	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—GSTM1—glaucoma	9.01e-05	0.000514	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—CDKN2B—glaucoma	8.98e-05	0.000512	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—NGF—glaucoma	8.72e-05	0.000497	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—NGF—glaucoma	8.72e-05	0.000497	CbGpPWpGaD
Fingolimod—CYP2E1—Biological oxidations—GSTM1—glaucoma	8.65e-05	0.000494	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—APOE—glaucoma	8.63e-05	0.000492	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—NTRK1—glaucoma	8.62e-05	0.000492	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—EDN1—glaucoma	8.61e-05	0.000492	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—C3—glaucoma	8.61e-05	0.000491	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—CAV1—glaucoma	8.55e-05	0.000488	CbGpPWpGaD
Fingolimod—CYP2E1—Metapathway biotransformation—GSTM1—glaucoma	8.53e-05	0.000487	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—C3—glaucoma	8.29e-05	0.000473	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—C3—glaucoma	8.29e-05	0.000473	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—APOE—glaucoma	8.01e-05	0.000457	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—MTHFR—glaucoma	7.96e-05	0.000454	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—CDKN2B—glaucoma	7.94e-05	0.000453	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—CAV1—glaucoma	7.94e-05	0.000453	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—NGF—glaucoma	7.91e-05	0.000452	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—APOE—glaucoma	7.71e-05	0.00044	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—APOE—glaucoma	7.71e-05	0.00044	CbGpPWpGaD
Fingolimod—CYP2D6—Biological oxidations—CYP1B1—glaucoma	7.68e-05	0.000438	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—CAV1—glaucoma	7.64e-05	0.000436	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—CAV1—glaucoma	7.64e-05	0.000436	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—EDN1—glaucoma	7.62e-05	0.000435	CbGpPWpGaD
Fingolimod—CYP2D6—Metapathway biotransformation—CYP1B1—glaucoma	7.57e-05	0.000432	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—FN1—glaucoma	7.56e-05	0.000431	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—C3—glaucoma	7.52e-05	0.000429	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—NOS3—glaucoma	7.49e-05	0.000427	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—BAD—glaucoma	7.47e-05	0.000426	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—APOE—glaucoma	7.41e-05	0.000423	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—CAV1—glaucoma	7.35e-05	0.000419	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—FN1—glaucoma	7.27e-05	0.000415	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—FN1—glaucoma	7.27e-05	0.000415	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—BAD—glaucoma	7.19e-05	0.00041	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—BAD—glaucoma	7.19e-05	0.00041	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—NGF—glaucoma	7e-05	0.0004	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—APOE—glaucoma	7e-05	0.0004	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—CAV1—glaucoma	6.94e-05	0.000396	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—PTGS2—glaucoma	6.85e-05	0.000391	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—NARFL—glaucoma	6.75e-05	0.000385	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—CA5A—glaucoma	6.75e-05	0.000385	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—C3—glaucoma	6.66e-05	0.00038	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—FN1—glaucoma	6.61e-05	0.000377	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—BAD—glaucoma	6.53e-05	0.000372	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—NOS3—glaucoma	6.46e-05	0.000369	CbGpPWpGaD
Fingolimod—CYP3A4—Biological oxidations—GSTT1—glaucoma	6.3e-05	0.00036	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—APOE—glaucoma	6.2e-05	0.000354	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—CAV1—glaucoma	6.14e-05	0.000351	CbGpPWpGaD
Fingolimod—CYP2D6—Biological oxidations—GSTM1—glaucoma	6.14e-05	0.00035	CbGpPWpGaD
Fingolimod—CYP2D6—Metapathway biotransformation—GSTM1—glaucoma	6.05e-05	0.000345	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—NOS3—glaucoma	6e-05	0.000343	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—PTGS2—glaucoma	5.91e-05	0.000337	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—FN1—glaucoma	5.85e-05	0.000334	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—NOS3—glaucoma	5.78e-05	0.00033	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—NOS3—glaucoma	5.78e-05	0.00033	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—BAD—glaucoma	5.78e-05	0.00033	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—NOS3—glaucoma	5.55e-05	0.000317	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—NOS3—glaucoma	5.25e-05	0.000299	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—CDKN1B—glaucoma	5.2e-05	0.000297	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—PTGS2—glaucoma	5.08e-05	0.00029	CbGpPWpGaD
Fingolimod—CYP3A4—Biological oxidations—CYP1B1—glaucoma	5.02e-05	0.000286	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—CDKN1B—glaucoma	5.01e-05	0.000286	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—CDKN1B—glaucoma	5.01e-05	0.000286	CbGpPWpGaD
Fingolimod—CYP3A4—Metapathway biotransformation—CYP1B1—glaucoma	4.95e-05	0.000283	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—MMP9—glaucoma	4.82e-05	0.000275	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—CA1—glaucoma	4.65e-05	0.000265	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—NOS3—glaucoma	4.64e-05	0.000265	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—MMP9—glaucoma	4.64e-05	0.000265	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—MMP9—glaucoma	4.64e-05	0.000265	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—CDKN1B—glaucoma	4.55e-05	0.000259	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—CTSA—glaucoma	4.5e-05	0.000257	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—CA5A—glaucoma	4.42e-05	0.000252	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—NARFL—glaucoma	4.42e-05	0.000252	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—VEGFA—glaucoma	4.33e-05	0.000247	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—CA2—glaucoma	4.25e-05	0.000243	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—MMP9—glaucoma	4.21e-05	0.00024	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—VEGFA—glaucoma	4.16e-05	0.000238	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—VEGFA—glaucoma	4.16e-05	0.000238	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—CDKN1B—glaucoma	4.02e-05	0.00023	CbGpPWpGaD
Fingolimod—CYP3A4—Biological oxidations—GSTM1—glaucoma	4.01e-05	0.000229	CbGpPWpGaD
Fingolimod—CYP3A4—Metapathway biotransformation—GSTM1—glaucoma	3.96e-05	0.000226	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—VEGFA—glaucoma	3.78e-05	0.000216	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—MMP9—glaucoma	3.73e-05	0.000213	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—VEGFA—glaucoma	3.35e-05	0.000191	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—CA1—glaucoma	3.3e-05	0.000188	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—TP53—glaucoma	3.27e-05	0.000187	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—CTSA—glaucoma	3.19e-05	0.000182	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—TP53—glaucoma	3.15e-05	0.00018	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—TP53—glaucoma	3.15e-05	0.00018	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—CA2—glaucoma	3.02e-05	0.000172	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—TXN—glaucoma	3e-05	0.000171	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—TP53—glaucoma	2.86e-05	0.000163	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—TP53—glaucoma	2.53e-05	0.000144	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—GSTT1—glaucoma	2.32e-05	0.000133	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—CA1—glaucoma	2.16e-05	0.000123	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—TXN—glaucoma	2.13e-05	0.000121	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—CTSA—glaucoma	2.09e-05	0.000119	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—CA2—glaucoma	1.97e-05	0.000113	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—ABCA1—glaucoma	1.85e-05	0.000106	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—CYP1B1—glaucoma	1.85e-05	0.000106	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—GSTT1—glaucoma	1.65e-05	9.4e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—GSTM1—glaucoma	1.48e-05	8.44e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—TXN—glaucoma	1.39e-05	7.93e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—CYP1B1—glaucoma	1.31e-05	7.49e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—ABCA1—glaucoma	1.31e-05	7.49e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—MTHFR—glaucoma	1.31e-05	7.46e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—APOE—glaucoma	1.22e-05	6.95e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—CAV1—glaucoma	1.21e-05	6.88e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—GSTT1—glaucoma	1.08e-05	6.15e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—GSTM1—glaucoma	1.05e-05	5.99e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—MTHFR—glaucoma	9.28e-06	5.29e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—NOS3—glaucoma	9.12e-06	5.2e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—APOE—glaucoma	8.64e-06	4.93e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—CYP1B1—glaucoma	8.58e-06	4.9e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—ABCA1—glaucoma	8.58e-06	4.9e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—CAV1—glaucoma	8.56e-06	4.88e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PTGS2—glaucoma	8.34e-06	4.76e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—GSTM1—glaucoma	6.86e-06	3.92e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—NOS3—glaucoma	6.47e-06	3.69e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—MTHFR—glaucoma	6.07e-06	3.46e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PTGS2—glaucoma	5.92e-06	3.38e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—APOE—glaucoma	5.65e-06	3.22e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—CAV1—glaucoma	5.59e-06	3.19e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—NOS3—glaucoma	4.23e-06	2.41e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PTGS2—glaucoma	3.87e-06	2.21e-05	CbGpPWpGaD
